Pharmacotherapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.0 | Q2 | 69.7% | 1.189 | Q1 | 87.9% |
| 2024 | 3.4 | Q2 | 68.3% | 0.990 | Q1 | 84.0% |
| 2023 | 2.9 | Q2 | 59.1% | 0.943 | Q1 | 84.0% |
| 2022 | 4.1 | Q2 | 72.5% | 0.968 | Q1 | 85.5% |
| 2021 | 6.3 | Q1 | 87.5% | 1.308 | Q1 | 91.3% |
| 2020 | — | — | 1.227 | Q1 | 89.3% | |
| 2019 | — | — | 1.066 | Q1 | 87.0% | |
| 2018 | — | — | 1.156 | Q1 | 87.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0277-0008
ISSN
1875-9114
region
Northern America
coverage
1981-2026